What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
His primary scientific interests are in Internal medicine, Cardiology, Surgery, Myocardial infarction and Heart failure.
His research in Internal medicine intersects with topics in Diabetes mellitus and Endocrinology.
His Cardiology research is multidisciplinary, relying on both ACE inhibitor, Valsartan and Randomization.
His Surgery research includes themes of Platelet, Angiotensin-converting enzyme and Cause of death.
His work on Thrombolysis, Streptokinase, ST elevation and Angina is typically connected to In patient as part of general Myocardial infarction study, connecting several disciplines of science.
His studies examine the connections between Heart failure and genetics, as well as such issues in Placebo, with regards to Clinical endpoint and Renin–angiotensin system.
His most cited work include:
- Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. (5461 citations)
- A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. (2495 citations)
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials (1677 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Cardiology, Surgery, Myocardial infarction and Heart failure.
His Internal medicine study combines topics in areas such as Diabetes mellitus and Endocrinology.
His study in Cardiology is interdisciplinary in nature, drawing from both Valsartan and Placebo.
His Surgery research is multidisciplinary, incorporating elements of Odds ratio, Aspirin, Epidemiology and Confidence interval.
His Heart failure research is multidisciplinary, incorporating perspectives in Heart disease, Proportional hazards model and Hazard ratio.
He has included themes like Meta-analysis, Clinical trial and Intensive care medicine in his Randomized controlled trial study.
He most often published in these fields:
- Internal medicine (46.36%)
- Cardiology (21.71%)
- Surgery (15.81%)
What were the highlights of his more recent work (between 2009-2021)?
- Internal medicine (46.36%)
- Cardiology (21.71%)
- Heart failure (14.26%)
In recent papers he was focusing on the following fields of study:
Gianni Tognoni mainly investigates Internal medicine, Cardiology, Heart failure, Randomized controlled trial and Surgery.
His study in Diabetes mellitus extends to Internal medicine with its themes.
His Cardiology research includes elements of Valsartan, Placebo and Impaired glucose tolerance.
His Heart failure study incorporates themes from Endocrinology, Renal function, Rosuvastatin and Intensive care medicine.
The various areas that he examines in his Randomized controlled trial study include Anesthesia, Relative risk, Adverse effect, Meta-analysis and Prospective cohort study.
While the research belongs to areas of Surgery, he spends his time largely on the problem of Myocardial infarction, intersecting his research to questions surrounding Statin.
Between 2009 and 2021, his most popular works were:
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials (1677 citations)
- Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials (614 citations)
- Albumin Replacement in Patients with Severe Sepsis or Septic Shock (609 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
His main research concerns Internal medicine, Randomized controlled trial, Heart failure, Cardiology and Surgery.
His work deals with themes such as Diabetes mellitus and Endocrinology, which intersect with Internal medicine.
His Randomized controlled trial study integrates concerns from other disciplines, such as Clinical trial, Kidney disease, Relative risk, Meta-analysis and Atrial fibrillation.
He combines subjects such as Renal function, Intensive care medicine, Urinary system, Rosuvastatin and Excretion with his study of Heart failure.
His biological study spans a wide range of topics, including Valsartan, Interquartile range and Randomization.
His research integrates issues of Hemodynamics, Aspirin and Incidence in his study of Surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
